Strengthening Strategic International Collaboration: Concord Medical Delegation Visits Mayo Clinic, Marking a New Phase in Global Development

---

From May 18 to 22, 2026, a delegation from Concord Medical Group, accompanied by key members of the leadership team from Shijiazhuang Edison Cancer Hospital, visited Mayo Clinic's Florida campus in the United States for a five-day high-level strategic exchange. More than 40 senior experts from Mayo Clinic, representing clinical, nursing, and administrative disciplines, participated throughout the program.

During the visit, Mayo Clinic provided a comprehensive introduction to its development history, mission, core values, and campus master planning strategy. Department leaders and subject-matter experts shared insights into globally advanced operational models and technological innovations across key specialties, including proton therapy and radiation oncology, breast cancer care, lung cancer care, gastrointestinal oncology, pharmacy management, pathology, and telemedicine.

The Concord Medical delegation also toured treatment centers and inpatient units, gaining firsthand exposure to clinical workflows, multidisciplinary care practices, and intelligent healthcare applications. Through in-depth discussions and knowledge exchange, both sides explored a wide range of topics, including oncology care models, healthcare quality management, comprehensive patient-centered care, and patient experience enhancement.

The delegation additionally visited a premium health management center to identify potential pathways for future collaboration in preventive healthcare and health management services — signaling a broader vision that extends beyond oncology into comprehensive wellness and early intervention.

Building on a long-standing partnership characterized by aligned values and effective implementation, the Shijiazhuang Edison Cancer Hospital project has become a model of collaboration between the two organizations. In recognition of its success, the project was selected for inclusion in Mayo Clinic's official International Consulting Services project portfolio — a distinction that underscores the depth and quality of the collaboration.

Senior executives from Mayo Clinic spoke highly of the shared commitment to excellence demonstrated by both organizations and commended the outcomes of the visit. They expressed confidence in the continued advancement of the Shijiazhuang Edison project and its role as a flagship initiative supporting Concord Medical's international expansion and high-quality development strategy.

"The shared commitment to excellence demonstrated by both organizations has been truly commendable. We have full confidence in the continued advancement of the Shijiazhuang Edison project and its pivotal role as a flagship initiative in Concord Medical's international development strategy." — Senior Executives, Mayo Clinic

Looking ahead, Concord Medical will continue to deepen cooperation with leading global healthcare institutions, leveraging international expertise and best practices to enhance clinical excellence, operational capabilities, and patient-centered services. Through these efforts, the Group aims to further strengthen its global healthcare network and accelerate the implementation of its international development strategy.